Following the manufacture of sufficient supplies of the drug compound by ANP?s technology partner, Isis Pharmaceuticals Inc., ANP has now commenced formulation of this raw material into injectible product to be used in the clinical trial. This drug product formulation work should be completed in April 2011.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.002(22.2%) |
Mkt cap ! $11.96M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.3¢ | 1.0¢ | $215.5K | 19.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 11300000 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 800000 | 3 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| PER (ASX) Chart |